Appraisal of cardiac ejection fraction with liver disease severity: Implication in post-liver transplantation mortality

Hepatology

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation

Liver Transpl

Younossi ZM

doi: 10.1002/lt.25003.

Hepatology

Stabilisation of acute-on-chronic liver failure patients before liver transplantation predicts post-transplant survival

Aliment Pharmacol Ther.

Huebener P, Sterneck MR, Bangert K, Drolz A, Lohse AW, Kluge S, Fischer L, Fuhrmann V

doi: 10.1111/apt.14627.

Gallbladder and Biliary Diseases

The gastroenterologist's guide to management of the post-liver transplant patient

Am J Gastroenterol.

Chascsa DM, Vargas HE

doi: 10.1038/s41395-018-0049-0.

Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy

Dig Dis Sci.

Gadiparthi C, Cholankeril G, Yoo ER, Hu M, Wong RJ, Ahmed A

doi: 10.1007/

Hepatology

Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates

Hepatology.

Kardashian A, Ge J, McCulloch CE, Kappus MR, Dunn MA, Duarte-Rojo A, Volk ML, Rahimi RS, Verna EC, Ganger DR, Ladner D, Dodge JL, Boyarsky B, McAdams-DeMarco M, Segev DL, Lai JC

doi: 10.1002/hep.31406.

Hepatology

Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failuare

J Hepatol.

Hernaez R, Liu Y, Kramer JR, Rana A, El-Serag HB, Kanwal F

doi: 10.1016/j.jhep.2020.06.005.

Gastrointestinal Diseases

Liver transplantation for alcohol-related liver disease in the UK: revised UK Liver Advisory Group recommendations for referral

Lancet Gastroenterol Hepatol

Masson S, Aldersley H, Leithead JA, Day E, Langford A, Healy P, O'Grady J, Thorburn D, Parker C, Shepherd L, Arndtz K, Webb K, Holt A

doi: 10.1016/S2468-1253(21)00195-3

Gastrointestinal Cancer

Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease

Clin Gastroenterol Hepatol.

Vaughn BP, Rank KM, Khoruts A

doi: 10.1016/j.cgh.2018.07.026.

Hepatology

Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation

J Hepatol.

Giannelli V, Roux O, Laouénan C, Manchon P, Ausloos F, Bachelet D, Rautou PE, Weiss E, Moreau R, Mebazaa A, Cohen-Solal A, Durand F, Francoz C

doi: 10.1016/j.jhep.2019.10.002.

Related content

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation

Stabilisation of acute-on-chronic liver failure patients before liver transplantation predicts post-transplant survival

The gastroenterologist's guide to management of the post-liver transplant patient

Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy

Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates

Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failuare

Liver transplantation for alcohol-related liver disease in the UK: revised UK Liver Advisory Group recommendations for referral

Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease

Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation